Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Guangzhou Manjing Biomedicine Technology Co., Ltd

Clinical trials sponsored by Guangzhou Manjing Biomedicine Technology Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug NT-88 aims to improve heart function in early trial Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New drug NT-88 aims to improve heart function in early trial

Disease control Not yet recruiting

This study tests a new drug called NT-88 (Zuozhu Daxi) in 60 adults with heart failure where the heart's pumping ability is mildly reduced. Participants will receive either standard heart failure drugs or standard drugs plus NT-88. The goal is to check safety and see if NT-88 can…

Sponsor: Guangzhou Manjing biomedicine technology co., ltd • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC